These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16650772)

  • 1. Vaccine-derived poliovirus from long term excretors and the end game of polio eradication.
    Martín J
    Biologicals; 2006 Jun; 34(2):117-22. PubMed ID: 16650772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term excretion of vaccine-derived poliovirus by a healthy child.
    Martín J; Odoom K; Tuite G; Dunn G; Hopewell N; Cooper G; Fitzharris C; Butler K; Hall WW; Minor PD
    J Virol; 2004 Dec; 78(24):13839-47. PubMed ID: 15564492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus.
    Friedrich F
    Acta Virol; 2000 Apr; 44(2):109-17. PubMed ID: 10989702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa.
    Pavlov DN; Van Zyl WB; Van Heerden J; Kruger M; Blignaut L; Grabow WO; Ehlers MM
    J Appl Microbiol; 2006 Dec; 101(6):1367-79. PubMed ID: 17105568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
    Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
    Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication.
    Cáceres VM; Sutter RW
    Clin Infect Dis; 2001 Aug; 33(4):531-41. PubMed ID: 11462191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrupting wild poliovirus transmission using oral poliovirus vaccine: environmental surveillance in high-risks area of India.
    Chowdhary R; Dhole TN
    J Med Virol; 2008 Aug; 80(8):1477-88. PubMed ID: 18551602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
    Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E
    Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication.
    Minor P
    Vaccine; 2009 May; 27(20):2649-52. PubMed ID: 19428874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on vaccine-derived polioviruses.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Oct; 55(40):1093-7. PubMed ID: 17035927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination strategies for the last stages of global polio eradication.
    Bompart F
    Indian Pediatr; 2005 Feb; 42(2):163-9. PubMed ID: 15767713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poliovirus vaccine strains detected in stool specimens of immunodeficient children in South Africa.
    Pavlov DN; Van Zyl WB; Kruger M; Blignaut L; Grabow WO; Ehlers MM
    Diagn Microbiol Infect Dis; 2006 Jan; 54(1):23-30. PubMed ID: 16290028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan.
    Horie H; Yoshida H; Matsuura K; Miyazawa M; Wakabayashi K; Nomoto A; Hashizume S
    J Med Virol; 2002 Nov; 68(3):445-51. PubMed ID: 12226835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The spread of the wild Poliovirus in the rural environment, the case of the Adzopé health district, Côte d'Ivoire].
    Akoua-Koffi CG; Nekouressi G; Tieoulou L; Guillot S; Faye-Kette H; Ehouman A
    Bull Soc Pathol Exot; 2004 May; 97(2):87-90. PubMed ID: 15255346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurovirulence of Sabin 1-derived polioviruses isolated from an immunodeficient patient with prolonged viral excretion.
    Yoneyama T; Yoshida H; Shimizu H; Yoshii K; Nagata N; Kew O; Miyamura T
    Dev Biol (Basel); 2001; 105():93-8. PubMed ID: 11763343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged poliovirus excretion in an immunodeficient person with vaccine-associated paralytic poliomyelitis.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Jul; 46(28):641-3. PubMed ID: 9233551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks of reintroduction of polio after eradication: the vaccine origin of an outbreak of type 3 poliomyelitis.
    Martin J; Ferguson GL; Wood DJ; Minor PD
    Dev Biol (Basel); 2001; 105():83-92. PubMed ID: 11763341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis.
    Khetsuriani N; Prevots DR; Quick L; Elder ME; Pallansch M; Kew O; Sutter RW
    J Infect Dis; 2003 Dec; 188(12):1845-52. PubMed ID: 14673763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gaps in scientific knowledge for the post eradication world.
    Minor P
    Biologicals; 2006 Jun; 34(2):167-70. PubMed ID: 16678439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on vaccine-derived polioviruses--worldwide, January 2008-June 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(36):1002-6. PubMed ID: 19763076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.